Previous studies have shown that elevated basal homocysteine levels are correlated among family members of patients with coronary vascular disease and juvenile venous thrombosis. This suggests the possibility of the presence of inherited basal mild hyperhomocysteinemia (mHH). We studied homocysteine levels, fasting as well as after methionine load, among 96 family members of 21 post-load hyperhomocysteinemic vascular index patients, i.e. 6 parents, 27 offspring, 38 siblings, 19 uncles and aunts and 6 cousins. In 15 out of 21 screened families post-load ml-IH was esti in at least one family member. Fa:>ting and post-load mHH was observed in 19 out of 89 (21%) screened family members (fasting homocysteine levels not measured in seven family members), and 31 out of 96 screened family members (32%), respectively. In 40% of all family members, post-load mHH was not accompanied by fasting mHH.
Introduction
Mild hyperhomocysteinemia (mHH), a risk factor lor premature i is detected in a frequency of 9 47% in patients with premature al or coronary stenotic arterial [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . In the cerebral, disease or with 72
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Homocysteine blood concentrations were found to be correlated in monozygotic and dizygotic healthy twins [18, 19] and were strongly correlated among family members of patients with coronary vascular disease [20] [21] [22] . These studies in family members of arterial occlusive diseased patients were performed on the base of fasting homocys teine concentration measurements only. Falcon et value < 6.5 mmol/1), in the index patient of family 13 (7.7 mmol/1), hypertriglyceridemia was detected in the index patient of family 8 (5.46 mmol/1; reference value < 2.00 mmol/1), and diabetes in the index patient of family 3 (fasting glucose: 9.4 mmol/1; reference value > 7.8 mmol/ 1). All other index patients and family members had vitamin B6, vitamin B]2, folic acid, glucose, al. [8] reported high plasma homocysteine levels in 5 out of 8 families of patients with juvenile venous thrombosis.
In the present study, we have performed me thionine loading tests in 96 family members of 21 hyperhomocysteinemic vascular patients. In these patients as well as their family members vitamin deficiencies or liver or renal failure which could lead to secondary mHH had been excluded. The prevalence of mHH, fasting as well as after me thionine loading, among the family members was assessed to examine the possibility of the presence of an inherited cause of mHH in the vascular cholesterol, triglycerides levels within the normal ranges, were without liver or renal disease or hypertension of non-renovascular origin. From all patients and the family members information of intake of vitamin supplements and medical his tory was obtained. None of the 21 families and the studied parents were related to one other within the second generation. In 21 vascular disease patients hyperhomocys teinemia was established on the basis of their homocysteine level after methionine loading ex ceeding the mean + 2 S.D.s post-load homocys teine level in 95 controls. Methionine loading tests (0.1 g L-methionine/kg body weight) were permembers according to a formed in protocol reported previously [23] . Plasma samples in the fasting state and 6 h after methionine load concomitant coronary occlusive arterial disease and deep crural thrombosis. One family (Fig. I , family number 13) was also known with inherited protein C-deficiency [25] . The vascular disease became symptomatic in the index patients be tween their 16th and 50th year of age (38 + 8 years; mean ± S.D.), the mean age ± S.D. at their screening was 39 ± 7 years.
Index vascular patients

Family members
were collected and centrifuged instantly. The total homocysteine concentration (free plus proteinbound) was measured by high-performance liquid The methionine loading tests in the studied family members were performed on their own chromatography (HPLC) [24] . At the time of request after detection of the index patient, except screening, the index patient of family 10, his for 2 families ( 
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75 and 43 female); i.e. 6 parents, 27 offspring and 39 siblings. In family number 10 and 13 ( Fig. 1 ) 10 uncles and 9 aunts were also tested. These second degree family members were siblings of the fathers of both index cases in whom post-load mHH was revealed. In family number 10 another 6 third degree relatives (offspring of a post-load hyperho mocysteinemic second degree were screened with the methionine loading test. At the time of screening the mean age + S.D. of the 97 family members was 33 + 9 years (range 12-68 years). One sister used ments and was excluded from the study (Fig. 1 , family number 7). Four family members suffered from vascular complications at the time of screen ing ( Fig. 1 , family number 4, 7, 13, 15). Their age at onset of vascular complications ranged from 37 to 59 years of age (mean + S.D. 44 + 8 years).
Control subjects
Because of previously observed differences in mean fasting and post-load homocysteine levels between male, pre-menopausal and postmenopausal female control subjects the studied index patients and family members were catego rized accordingly [3, 26] . The fasting and post-load homocysteine concentration (2.5-97.5 percentile) respectively was in control men 8-18 and 25-54 /miol/1 (n 23), in control pre-menopausal women 6-15 and 18-51 /¿mo I/I (n 46) and in control post-menopausal women 6-19 and 25-69 /¿mol/1 (n 26) [27] .
out of 19 screened second degree and 3 out of 7 screened third degree members revealed post-load mHH. By definition, the post-load ho mocysteine concentrations of vascular index pa tients, and post-load family members were significantly higher than in controls (Table 1) . Also the total group of studied xi sign than controls. Plasma folic acid concentrations vascular index patients, family members as one group and as subgroups with and without post load hyperhomocysteinemia, were statistically siglower compared to vitamin B6 was hyperhomocysteinemic family members (Table 1) .
Plasma in post-load
There was no evident sex difference among the hyperhomocysteinemic family members (17 of the 42 male, and 14 of the 54 female family members; X2 P > 0.05). Table 1 normal range in 6 out of 20 index patients family number 3, 4, 17, 18, 19, 20; fasting homo-, In cysteine level not measured in 1 index p< 5 out of the 6 families of these 6 patients, one more post-load member was detected, and also in all In 15 out of the 21 screened families post-load mHH was established in at least one family mem ber. In 31 out of 96 screened family post-load mHH was observed (32%). Post-load mHH was detected in 50%) of the parents (3 out of 6 parents), of the (7 out of 27 children) and in 29% of the siblings (11 out of 38 siblings among 16 index vascular patients). Seven post-load hyperhomocysteinemic family members, but also, albeit less strongly significantly, in post load normohomocysteinemic family members compared to the control group (Table 1) .
Fasting mild and
Discussion
Vascular complications in family members
Four screened family members were known with vascular manifestations at the time of the methionine loading test. Three of them revealed post-load mHH (Fig. 1, family number 4, 7 and  13 ). The fourth vascular affected family member (Fig. 1, family number 15) showed a high but normal post-load homocysteine concentration
In the present study, 71% of the families of a patient with various forms of arteriosclerosis had at least one other family member with post-load mHH. In 6 out of the 21 studied families no other relative had post-load mHH, but only 15 of the 40 first degree relatives were studied, and therefore, co uld have been missed. Mildly elevated homocysteine levels were present in family members in 21% on the base of fasting and in 32% on the base Table 1 Mean ± SD of laboratory characteristics of 21 ia, and 65 family members with post-load homocysteine concentration. Our obser vations are in line with previous reports in which basal homocysteine concentration in healthy twins and in families of coronary vascular patients is reported to show a significant correlation [18] [19] [20] [21] [22] . The present study demonstrates that both fasting and post-load mHH, in the absence of vitamin deficiencies and renal or liver insufficiencies, seems to be inherited in the majority of vascular patients. Further enzymatic and molecular studies are needed to reveal the involved genetic enzy matic defects and their inheritance patterns. Re duced activities in the range of obligate carriers for CS-deficiency have been reported in hyperhomocysteinemic vascular patients [3, 4] . This finding was difficult to reconcile with the conclusion by Mudd et al. of a normal incidence of heart attacks vascular [15, 30] . Moreover, in the Netherlands where the 833 T C transition is detectable as the mutation in the gene on chromosome 21 in 50% of alleles of homozygotes for CS-deficiency, in 60 cardiovascular pati this mutation not be identified in them [30] . The same holds true for the tion in Ireland the CS the 919 G "+ A mutation in in 70% of could not be in a group of 100 Irish patients with . From all these enzymatic and molecular ss summarizing, it can that there is no evidence, so far, that ity for deficiency plays a role as the basis of mHH in vascular patients. In a previous study, we an incidence of a thermolabile MTHFR o r in a large group of obligate erozygotes for CS-deficiency studied by question naires [28] . Furthermore, even in populations with the highest prevalence of homozygous CS-defi ciency, such as in Ireland, the calculated number of carriers is too low to account for the number of observed hyperhomocysteinemic vascular patients [29] . Indeed, very recently, it was reported that the finding of lowered CS-activity was not repro ducible in 96% of studied hyperhomocysteinemic to produce a MTHFR patients and lively [30] , [13, 14] . s, i.e. 28% i 5%, of this defect does not seem sufficient to provide on its own the base of all familial occurrence of mHH as observed in the present study.
It is still questionable whether, either fasting or post-load homocysteine concentration, is the most sensitive indicator of abnormal homocysteine metabolism. Both fasting and post-load mHH are considered risk factors for cardiovascular disease [1, 5, 32] . In case we screened for mHH only on the basis of fasting homocysteine levels, no more than 14 out of 20 index patients (70%) and 17 out of 29 members with post-load mHH (59%) would have been considered hyperhomocysteinemic. Even if family members of only the 14 index patients with fasting mHH had been screened for fasting homocysteine levels alone, 29% (7 out of 24) of the family members who indeed showed post-load mHH, would have been classified as normohomocysteinemic. Post-load elevated ho mocysteine levels in the absence of fasting hyperhomocysteinemia is probably on the basis of another enzymatic defect than concomitant fast ing and post-load hyperhomocysteinemia [33] . In our present study, we have screened family mem bers of vascular index patients with post-load elevated homocysteine levels, in whom only in 70% also abnormal fasting levels were present. None of the 21 index patients were known with fasting elevated and post-load normal homocys teine concentrations. Therefore, a selection in families has been made on the basis of this inclu sion criterion. However, studies on fasting homo cysteine levels in healthy twins and also in families of cardiovascular patients have been performed already previously, showing a strong correlation [18] [19] [20] [21] [22] . We prefer to perform both fasting and post-load homocysteine concentrations in vascu lar patients and family members to investigate their individual homocysteine status more com pletely [11, 25, [34] [35] [36] [37] .
Plasma folic acid concentrations, were signifimic family members lower folic acid compared to controls, could be an indication of a common habit of low folate intake in these families, leading to hyperhomocysteinemia in some of the mem bers. However, in family members with hyperho mocysteinemia, the decrease in folic acid concentration was much more pronounced than in their normohomocysteinemic family members, comparable with the highly significantly lower levels in the vascular patients in these families. This is much more suggestive of the presence of a hereditary defect in homocysteine metabolism leading to a higher demand for folate in the hyperhomocysteinemic patients and their hyperhomocysteinemic family members. Among the 96 investigated family members, 4 had known vascular disease. Three of them were hyperhomocysteinemic, and one had high-normal post-load homocysteine concentration. Therefore, screening for mHH of family members suffering from vascular events among families of a hyper homocysteinemic patient, is recommended. About 90% of the family members with post-load mHH revealed no subjective signs of vascular disease, at least so far. Most screened family members were younger than their respective index case. This suggests that familial mild hyperhomocysteinemia i leading to symptomatic vascular disease has a low expression, may be age dependent and that homo cysteine in mild excess may require more trigger ing factors. mHH in vascular patients can be normalized by vitamin B6 and/or folic acid treatment [11, 25, [34] [35] [36] [37] . In case homocysteine-lowering intervention in hyperhomocysteinemic vascular patients and their hyperhomocysteinemic family members is clini cally beneficial in terms of preventing recurrent and first occurrence of arterial disease, respec tively, such treatment will be of significant impor tance in general health care. cantly lower in vascular index patients, in family members as one group, and in the subgroups of post-load normo-and hyperhomocysteinemic
